Cholinesterase Inhibitors

Background Dementia is caused by a variety of neurodegenerative diseases and is associated with a decline in memory and other cognitive abilities, while inflicting an enormous socioeconomic burden. The complexity of dementia and its associated comorbidities presents immense challenges for dementia research and care, particularly in clinical decision-making. Main body Despite the lack of disease-modifying therapies, there is an increasing and urgent need to make timely and accurate clinical decisions in dementia diagnosis and prognosis to allow appropriate care and treatment. However, the dementia care pathway is currently suboptimal. We propose that through computational approaches, understanding of dementia aetiology could be improved, and dementia assessments could be more standardised, objective and efficient. In particular, we suggest that these will involve appropriate data infrastructure, the use of data-driven computational neurology approaches and the development of practical clinical decision support systems. We also discuss the technical, structural, economic, political and policy-making challenges that accompany such implementations. Conclusion The data-driven era for dementia research has arrived with the potential to transform the healthcare system, creating a more efficient, transparent and personalised service for dementia.

show abstract

Cholinesterase Inhibitors

Cited by 3 publications

References 15 publications

Focus on Neurochemistry Led to the Cholinergic Hypothesis of Alzheimer’s Disease

Focus on Neurochemistry Led to the Cholinergic Hypothesis of Alzheimer’s Disease

Microencapsulation and nanoencapsulation of bacterial probiotics: new frontiers in Alzheimer's disease treatment

Shaping a data-driven era in dementia care pathway through computational neurology approaches

Contact Info

Product

Resources

About